Research Article
Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders
Table 1
Univariate analysis of clinical characteristics in 279 MCI patients who remained stationary course or progressed to dementia.
| | Stable MCI | Dementia | value | (percentage) | (percentage) |
| Etiology | AD 98 (56) | AD 65 (62.5) | 0.268 | VaD 42 (24) | VaD 26 (25) | LBD 35 (20) | LBD 13 (12.5) | Age of onset | 70.9 | 74.7 | <0.001 | Female | 100 (57.1) | 48 (46.2) | 0.098 | Education | 6.9 | 7.3 | 0.425 | CDR-SB | 2.20 | 2.96 | <0.001 | MMSE | 24.5 | 23.3 | 0.004 | Hypertension | 101 (57.7) | 63 (60.6) | 0.954 | DM | 51 (29.1) | 38 (36.5) | 0.373 | Dyslipidemia | 90 (51.4) | 39 (37.5) | 0.021 | Liver disease | 24 (13.7) | 19 (18.3) | 0.279 | Renal disease | 20 (11.4) | 14 (13.5) | 0.844 | Gastrointestinal disease | 82 (46.9) | 50 (48.1) | 0.942 | Anemia | 10 (5.7) | 7 (6.7) | 0.918 | Heart disease | 73 (41.7) | 47 (45.2) | 0.894 | Stroke | 43 (24.6) | 25 (24) | 1.000 | Depression | 26 (14.9) | 25 (24) | 0.065 | Antidementia agents | 61 (34.9) | 69 (66.3) | <0.001 | Hypnotic agents | 61 (34.9) | 49 (47.1) | 0.064 | Polypharmacy | 103 (58.9) | 69 (67.0) | 0.314 |
|
|
AD: Alzheimer’s disease; VaD: vascular dementia; LBD: Lewy body diseases; MMSE: Mini-Mental State Examination; CDR-SB: Clinical Dementia Rating-Sum of Boxes; DM: diabetes mellitus. Remark: antidementia agents: acetylcholinesterase inhibitors and memantine. Hypnotic agents: benzodiazepines and nonbenzodiazepine hypnotics.
|